Trial Profile
Copaxone Adherence and Care Interrelations in Patients with Relapsing Multiple Sclerosis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2010
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms CAIR
- 24 Aug 2010 New trial record